BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25703212)

  • 1. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.
    Puig-Asensio M; Ruiz-Camps I; Fernández-Ruiz M; Aguado JM; Muñoz P; Valerio M; Delgado-Iribarren A; Merino P; Bereciartua E; Fortún J; Cuenca-Estrella M; Almirante B; ; ;
    Clin Microbiol Infect; 2015 May; 21(5):491.e1-10. PubMed ID: 25703212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.
    Puig-Asensio M; Padilla B; Garnacho-Montero J; Zaragoza O; Aguado JM; Zaragoza R; Montejo M; Muñoz P; Ruiz-Camps I; Cuenca-Estrella M; Almirante B; ; ;
    Clin Microbiol Infect; 2014 Apr; 20(4):O245-54. PubMed ID: 24125548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.
    Gamaletsou MN; Walsh TJ; Zaoutis T; Pagoni M; Kotsopoulou M; Voulgarelis M; Panayiotidis P; Vassilakopoulos T; Angelopoulou MK; Marangos M; Spyridonidis A; Kofteridis D; Pouli A; Sotiropoulos D; Matsouka P; Argyropoulou A; Perloretzou S; Leckerman K; Manaka A; Oikonomopoulos P; Daikos G; Petrikkos G; Sipsas NV
    Clin Microbiol Infect; 2014 Jan; 20(1):O50-7. PubMed ID: 23889746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
    Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
    J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
    Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
    Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.
    Chen CY; Huang SY; Tsay W; Yao M; Tang JL; Ko BS; Chou WC; Tien HF; Hsueh PR
    Int J Antimicrob Agents; 2012 Dec; 40(6):533-8. PubMed ID: 23006521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK.
    Chalmers C; Gaur S; Chew J; Wright T; Kumar A; Mathur S; Wan WY; Gould IM; Leanord A; Bal AM
    Mycoses; 2011 Nov; 54(6):e795-800. PubMed ID: 21615542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
    Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
    J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.
    Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Lepe-Jiménez JA
    J Antimicrob Chemother; 2013 Jan; 68(1):206-13. PubMed ID: 22945914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre® YeastOne® for Candida albicans: a prospective observational cohort study.
    van Hal SJ; Chen SC; Sorrell TC; Ellis DH; Slavin M; Marriott DM
    J Antimicrob Chemother; 2014 Aug; 69(8):2210-4. PubMed ID: 24788656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpoints.
    Gamaletsou MN; Daikos GL; Walsh TJ; Perlin DS; Ortigosa CJ; Psaroulaki A; Pagoni M; Argyropoulou A; Nepka M; Perivolioti E; Kotsopoulou M; Perloretzou S; Marangos M; Kofteridis D; Grammatikou M; Goukos D; Petrikkos G; Sipsas NV
    Int J Antimicrob Agents; 2014 Sep; 44(3):248-55. PubMed ID: 25108876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010.
    Chen PY; Chuang YC; Wang JT; Sheng WH; Yu CJ; Chu CC; Hsueh PR; Chang SC; Chen YC
    J Microbiol Immunol Infect; 2014 Apr; 47(2):95-103. PubMed ID: 23063082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
    Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
    J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance.
    Fernández-Ruiz M; Puig-Asensio M; Guinea J; Almirante B; Padilla B; Almela M; Díaz-Martín A; Rodríguez-Baño J; Cuenca-Estrella M; Aguado JM; ; ;
    J Infect; 2015 Sep; 71(3):385-94. PubMed ID: 26033696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.
    Cuervo G; Garcia-Vidal C; Nucci M; Puchades F; Fernández-Ruiz M; Obed M; Manzur A; Gudiol C; Pemán J; Aguado JM; Ayats J; Carratalà J
    Clin Microbiol Infect; 2016 Feb; 22(2):181-188. PubMed ID: 26460064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.
    Li Y; Du M; Chen LA; Liu Y; Liang Z
    Mycopathologia; 2016 Aug; 181(7-8):485-95. PubMed ID: 26994763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.
    Fernández-Ruiz M; Aguado JM; Almirante B; Lora-Pablos D; Padilla B; Puig-Asensio M; Montejo M; García-Rodríguez J; Pemán J; Ruiz Pérez de Pipaón M; Cuenca-Estrella M; ; ;
    Clin Infect Dis; 2014 May; 58(10):1413-21. PubMed ID: 24642553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008.
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; López J; Pitart C; Mensa J
    J Hosp Infect; 2011 Feb; 77(2):157-61. PubMed ID: 21216030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characteristics of bloodstream infections caused by Candida albicans in children from 2003 to 2011.
    Tsai MH; Wang SH; Hsu JF; Lin LC; Chu SM; Huang HR; Chiang MC; Fu RH; Lu JJ; Huang YC
    Clin Microbiol Infect; 2015 Nov; 21(11):1018.e1-8. PubMed ID: 26148466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.